Exploring the potential of circulating tumour DNA to monitor treatment response in salivary duct carcinoma patients of the CABO-ASAP trial.

Authors :: Weijers, J.A.M.
Bitter, T.J.J. de
Verhaegh, G.W.C.T.
Boxtel, W. van
Uijen, M.J.M.
Engen-van Grunsven, A.C.H. van
Driessen, C.M.L.
Schalken, J.A.
Ligtenberg, M.J.L.
Herpen, C.M.L. van
Weijers, J.A.M.
Bitter, T.J.J. de
Verhaegh, G.W.C.T.
Boxtel, W. van
Uijen, M.J.M.
Engen-van Grunsven, A.C.H. van
Driessen, C.M.L.
Schalken, J.A.
Ligtenberg, M.J.L.
Herpen, C.M.L. van
Source :: Oral Oncology, 147, pp. 106620
Publication Year :: 2023
Abstract: Contains fulltext : 300021.pdf (Publisher’s version ) (Closed access)<br />01 december 2023

Tools